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A comparison of the kinetic and other parameters of enzymes of flavin-nucleotide
metabolism in the whole foetus vis-a-vis the maternal liver in the pregnant rat revealed
relatively lower activities of foetal flavokinase and FAD pyrophosphorylase. Passive
immunoneutralization of the maternal riboflavin carrier protein suppresses foetal
FAD pyrophosphorylase rather selectively. Additionally, although the activities of
foetal nucleotide pyrophosphatase and FMN phosphatase were unchanged owing to
immunoneutralization, higher activities of these enzymes in the whole foetus as
compared with the maternal liver may be responsible for the drastic depletion ofFAD
levels that precipitates foetal degeneration.
Previously we provided biochemical (Muni-
yappa & Adiga, 1980a) and immunological
(Muniyappa & Adiga, 1980b) evidence in the
pregnant rat for a specific riboflavin carrier
protein obligatorily involved in transplacental
flavin transport to ensure uninterrupted vitamin
supply to the developing foetuses. The functional
importance of this maternal vitamin carrier was
shown by passive immunoneutralization, which
led to drastic curtailment of vitamin influx into the
foetoplacental unit, culminating in foetal wastage
and hence pregnancy termination (Murty & Adiga,
1981; Krishnamurthy et al., 1984). More recently
we demonstrated that one of the major conse-
quences of such acute foetal flavin deficiency
induced by immunological interference with the
functioning of this maternal protein was a drastic
disturbance in relative amounts of embryonic
flavin nucleotides, the most conspicuous being the
severely depleted FAD content (Krishnamurthy et
al., 1984). Whereas the latter aspect of disturbed
flavin metabolism is reminiscent of that encoun-
tered in a terminally differentiated tissue like the
liver of pregnant rats fed either a riboflavin-
deficient diet alone or one supplemented with
galactoflavin (Miller et al., 1962), or during
hypothyroid conditions (Rivlin & Langdon, 1965),
the relatively less pronounced changes in foetal
FMN and riboflavin concentrations in the face of
near-total depletion of FAD suggested that the
developing and differentiating foetus may be
endowed with a flavin metabolic machinery
qualitatively and/or quantitatively different from
that of the adult liver. To explore the above
possibility, the activities and kinetic properties of
the enzymes involved in flavin-nucleotide metabo-
lism of the maternal liver were compared with
those of the early foetuses. This also permitted the
delineation of the enzymic lesion responsible for
deranged flavin-nucleotide metabolism in foetuses
consequent on immunoneutralization of the mater-
nal vitamin carrier.
Experimental
Materials
ATP, NADPH, phosphoenolpyruvate, pyruvate
kinase, L-lactate dehydrogenase and catalase were
obtained from Sigma Chemical Co., St Louis, MO,
U.S.A. DL-Alanine was from Koch-Light Labora-
tories, Colnbrook, Slough, Berks., U.K. The
sources of other chemicals and biochemicals were
detailed previously (Krishnamurthy et al., 1984).
[2-' 4C]Riboflavin (sp. radioactivity 31 mCi/mmol)
was obtained from The Radiochemical Centre,
Amersham, Bucks., U.K.
Methods
Adult female albino rats (Wistar, 150g body wt.)
were kept for mating with fertile males and their
pregnancies monitored as described previously
(Murty & Adiga, 1981). For the assay of catabolic
enzymes, namely FMN phosphatase (acid phos-
phatase, EC 3.1.3.2) and nucleotide pyrophospha-
tase (EC 3.6.1.9), as well as of biosynthetic
enzymes, namely flavokinase (riboflavin kinase,
EC 2.7.1.26) and FAD pyrophosphorylase (FMN
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adenylyltransferase, EC 2.7.7.2), the animals were
killed on day 14 of pregnancy.
In all cases, the rats were killed 24h after the
administration of either non-immune rabbit serum
(O.5 ml/rat) for the control group or the antiserum
(0.2ml/rat) to purified riboflavin carrier protein
raised in rabbits. This dose of antiserum had
previously been shown to be effective for 1000
foetal rejection between 24 and 48h of antiserum
administration. A similar sequence of events was
observed when the antiserum was administered on
any day between day 6 and day 16 of pregnancy
(Muniyappa & Adiga, 1980b). The antiserum to
chicken riboflavin carrier protein could neutralize
480Mg of protein/ml of serum at equivalence point.
Sera were administered intraperitonially to day-1 3
pregnant rats. At 24h after antiserum administra-
tion, drastic foetal wastage, as indicated by 50-
60% decrease in fresh weight, was clearly evident.
Purification of chicken's-egg riboflavin carrier
protein and elicitation of antibodies to the purified
protein in rabbits was described previously (Murty
& Adiga, 1981).
After the animals had been killed by decapita-
tion, whole foetuses were removed and dissected
free of the maternal uterine covering, placenta and
the cord. The foetuses were then washed several
times with buffer until most of the blood was
removed. Before homogenization maternal livers
were perfused in situ for IOmin with the buffer used
for the particular enzyme assay until all the blood
was removed.
Homogenization was performed at 0-40C with a
Potter-Elvehjem homogenizer with seven to ten
strokes of the Teflon pestle. For all enzyme assays,
the foetuses and the maternal liver were separately
processed at 4°C, unless otherwise stated, and 10-
20% (w/v) homogenates were prepared, depending
on the enzyme to be assayed.
Protein was determined by the method of Lowry
et al. (1951), with crystalline bovine serum albumin
as standard. Sheep kidney apo-(D-amino-acid
oxidase) was partially purified by the method of
Burton (1955) and was stored as a freeze-dried
powder at 0-5°C until used. One unit of flavo-
kinase or FAD pyrophosphorylase activity is that
catalysing the formation of 1 nmol of product/h
under the experimental conditions employed.
Similarly, one unit of nucleotide pyrophosphatase
or FMN phosphatase activity is expressed as
1 nmol of substrate hydrolysed/min. For all en-
zymes, the specific and total activities are ex-
pressed as units/mg of protein and units/g of
tissue respectively. Km and Vma,. values were
determined by the Lineweaver-Burk plot and the h
value was calculated from the slope of Hill plot by
plotting log[(v/Vmax.)-v] against logs on a linear
scale (Segal, 1975).
Enzyme assays
FMN phosphatase. The enzyme extract was
prepared for assay as described by McCormick &
Russel (1962). The assay mixture (1.0ml) con-
tained 7.5 mM-potassium acetate buffer, pH 5.0,
2mM-FMN and 0.5mg of the enzyme protein
(McCormick, 1962). After incubation for 10min at
37°C in subdued light, the reaction was terminated
by spotting 100uI of the reaction mixture on to a
Whatman no. 3 paper. Flavins were resolved by
descending chromatography using butanol/acetic
acid/water (12:3:5, by vol.), and riboflavin quanti-
fied fluorimetrically with a Perkin-Elmer 203
spectrofluorimeter.
Nucleotide pyrophosphatase. For reproducible
quantification, it was found necessary to purify
this enzyme activity partially before assay by the
method of Krishnan & Rao (1972). The assay
mixture (1.0ml) contained 20mM-sodium carbon-
ate/sodium bicarbonate buffer, pH9.7, 0.2mM-
FAD and the enzyme protein (0.28mg). The
reaction mixture was incubated at 30°C for 1.5 min
and the reaction terminated by addition of 2 ml of
ethanol. The amount of FAD hydrolysed was
determined by measuring increase in flavin fluor-
escence (Bessey et al., 1949).
FAD pyrophosphorylase. FAD pyrophosphoryl-
ase was partially purified from the maternal liver
as well as from the foetuses as described by DeLuca
& Kaplan (1958). The reaction mixture (McCor-
mick, 1964) contained 25 mM-potassium phosphate
buffer, pH 7.5, 1 mM-ATP, 1 mM-MgCl2, 0.5mM-
FMN and the enzyme preparation (1.0mg) in a
total volume of 1.0ml. Incubation was carried out
in the dark for 60min at 37°C and the reaction
terminated by heating at 80°C for 5min. After
removing the precipitated protein by centrifuga-
tion, the supernatant was assayed for FAD by the
spectrophotometric method of McCormick (1964)
as modified by Rivlin (1969a), which employed
apo-(D-amino-acid oxidase).
Flavokinase. Flavokinase was partially purified
by the method of McCormick (1962) and the
activity determined as described by Merrill &
McCormick (1980) with slight modifications.
Assay mixtures (0.5 ml) contained 0.1 M-Tris/HCl,
pH 8.2 at 37°C, 1 mM-ATP, 1 mM-ZnCl,, 0.1 mM-
[2-'4C]riboflavin and the protein (hepatic, 1 mg;
foetal, 12 mg). After incubation for 60min in the
dark at 37°C, portions of the reaction mixture were
applied to Whatman no. 3 paper and chromato-
graphed with butanol/acetic acid/water (12:3:5,
by vol.). Radioactivities associated with FMN and
riboflavin regions were quantified by liquid-
scintillation spectrometry (Merrill & McCormick,
1980).
Foetal flavokinase was assayed essentially as
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described above, except that the reaction mixture
additionally contained an ATP-regenerating sys-
tem (20pg of pyruvate kinase and 1 mM-phos-
phoenolpyruvate).
Under the conditions of the assay employed, all
the reaction rates were linear with time and
proportional to the amount of enzyme protein
used. The substrate concentrations employed gave
optimal activities.
Results
FMNphosphatase activities in the maternal liver and
the foetus
The kinetic properties of the enzyme from the
two tissues are summarized in Table 1. Hepatic as
well as foetal FMN phosphatase showed compar-
able h values. Further, both the specific and total
activities were unaltered by passive immunoneu-
tralization of maternal riboflavin carrier protein
(Table 2). The Km values of the enzyme for FMN
differed only marginally, being 0.3mM and 0.7 mM
for liver and foetus respectively.
Nucleotide pyrophosphatase activities in the two
tissues
As shown in Table 1, the Km for FAD is almost
the same for the foetus enzyme as for that from
maternal liver. However, the foetal pyrophospha-
tase activity is about 4-fold higher than its hepatic
counterpart in terms of both specific as well as total
activity. Interestingly, no significant alteration in
the activities of the enzyme was noticeable on
immunoneutralization of riboflavin carrier protein
in the mother (Table 2).
Flavokinase activities in the foetal and the hepatic
tissues
The Km of the hepatic flavokinase for riboflavin
was 14mM as compared with 70pM for the foetal
enzyme (Table 1). It may be mentioned that the
foetal flavokinase could be assayed only after the
inclusion of an ATP-regenerating system in the
reaction mixture, which is suggestive of intrinsi-
cally higher ATPase activity, thus necessitating a
continuous supply of ATP for FMN production in
the foetal tissue. It is also noteworthy that, in
control animals, the hepatic flavokinase activity
was severalfold higher than its foetal counterpart;
however, under conditions of immunoneutraliza-
tion there was a 5-6-fold increase in foetal
flavokinase activity over the controls, whereas
hepatic activity remained unaltered under these
conditions (Table 2).
FAD pyrophosphorylase in the two tissues
The Km values for FAD of the foetal and the
hepatic enzymes were found to be 0.3 and 0.01 mM-
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respectively (Table 1). The higher Km of the foetal
pyrophosphorylase for FMN is suggestive of a
lower affinity of the enzyme for its substrate. The
hepatic pyrophosphorylase level was 2-fold higher
than its foetal counterpart and was unchanged on
immunoneutralization of riboflavin carrier protein
in the pregnant rat. Contrastingly, a 50% decrease
in the foetal enzyme activity was manifest under
the above conditions (Table 2). Since both specific
and total activities exhibited parallel trends, it
would appear that the decreased enzyme activity in
the affected foetuses reflects the situation in vivo
and is not a consequence of accelerated depletion
of its protein content by, presumably, catabolism.
Discussion
One of the remarkable features of the acute
flavin deficiency precipitated in the developing
foetus as a consequence of immunological inter-
ference with the maternal vitamin carrier is that,
instead of entering a quiescent stage due to
developmental arrest, the foetus undergoes rapid
degeneration, culminating in death. This contrasts
with the situation in certain tumours where
vitamin deficiency inhibits growth rather than
bringing about degeneration; the tumour tissue is
apparently more resistant than normal organs to
deficiency (Rivlin, 1973). Similarly, in adult
animals, dietary vitamin deficiency only sup-
presses growth rate without causing immediate
death. These observations seem to suggest subtle
differences in detail between the enzymes con-
cerned with flavin metabolism and regulation
thereof in the adult liver and foetus. The present
investigations largely support the above premise.
Thus, with regard to flavin-nucleotide-biosynthe-
tic enzymes, the significantly higher Km of the
foetal FAD pyrophosphorylase for FMN vis-a-vis
its hepatic counterpart (Table 1) is suggestive of a
need for a relatively higher intracellular FMN
concentration to drive the reaction in favour of
FAD synthesis. From the catalytic indices (repre-
sented by the Vmax/.Km ratio), it is clear that both
the biosynthetic enzymes of flavin-nucleotide
metabolism from the maternal liver are relatively
more efficient than their foetal counterparts (Table
1). Thus it would appear, perhaps surprisingly,
that, at the early stages of foetal growth, these
anabolic enzymes are relatively sluggish in activity
and less adapted to their function. A plausible
M. ,,,explanation for this finding may be concerned with
the fact that these biosynthetic enzymes in the
adult tissue are modulated by the thyroid hormones
(Greengard, 1971); on the other hand, in develop-
C _ ing rodent foetuses the thyroid becomes gradually
functional only during days 16-20 of gestation. It
was also shown that these enzymes increase slowly
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during foetal development to reach adult levels just
after birth (Rivlin, 1969b).
In contrast with the anabolic enzymes, the Km
values of the foetal flavin-degrading enzymes,
namely nucleotide pyrophosphatase and FMN
phosphatase, are more-or-less comparable with
their hepatic counterparts (Table 1). Furthermore,
whereas FMN phosphatases of the two tissues are
similar in terms of their catalytic indices, the foetal
nucleotide pyrophosphatase has a 7-8-fold higher
catalytic efficiency than the corresponding mater-
nal liver enzyme. It would appear therefore that,
superimposed on an inherently inefficient bio-
synthetic machinery concerned with the elabora-
tion of flavin coenzymes, acute flavin deficiency
precipitated by immunoneutralization of the car-
rier protein brings about a 50% decline in foetal
FAD pyrophosphorylase in the treated mothers
(Table 2). It is possible that a corresponding
increase in foetal flavokinase (Table 2) may
represent an adaptive, but unsuccessful, foetal
stratagem to offset the depressed FAD levels. It is
noteworthy that, unlike the situation in the flavin-
deficient adult liver, the foetal FAD is not
conserved at the expense of the more dispensable
FMN by an increase in FAD pyrophosphorylase
(Rivlin, 1969a). It would also appear that the FAD
pyrophosphorylase of the foetus is the pace-setting
enzyme in flavin-nucleotide biosynthesis and is
more stringently regulated by the available intra-
cellular riboflavin. It is intriguing that the degrada-
tion of FMN and FAD in foetuses seems to be
independent of riboflavin status, since the degrad-
ing enzymes remain unaltered both in flavin-
deficient foetuses and in the vitamin-deficient-
adult hepatic tissue (Lee & McCormick, 1983;
Fass & Rivlin, 1969).
From the abovementioned observations, it is
clear that there are certain basic differences in
enzyme profiles concerned with flavin-nucleo-
tide metabolism between the early foetus vis-a'-vis
the adult liver; in particular, the foetal biosynthe-
tic enzymes seem to be relatively sluggish, whereas
the reverse seems to be the case with the catabolic
enzymes. Although it is conceivable that some of
the differences in enzyme characteristics observed
are related to the different nature of the tissues
used for comparison, i.e. liver in the mother
and whole-body organs in the foetus. Interference
with the carrier-protein-mediated transplacental
vitamin-delivery mechanism, with the resultant
acute flavin deficiency (Murty & Adiga, 1981;
Krishnamurthy et al., 1984), seems to inhibit FAD
pyrophosphorylase selectively, leading to curtailed
FAD production. This situation, coupled with
relatively higher activities of FAD-catabolizing
enzymes in the foetus, apparently depletes the vital
coenzymes to such critically low levels that the
affected foetus is compelled to degenerate rapidly
in the absence of other regulatory (hormonal?)
mechanisms to offset this derangement. Further
experiments on the dynamics of flavin flow into
different flavin coenzymes in the affected foetuses
should substantiate the above conclusion.
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